CDER updates labeling on opioids, other abusable medications

New actions from the Food and Drug Administration (FDA) focus on the agency's Opioids Action Plan, first announced a year ago.
Source: The Brown University Child and Adolescent Psychopharmacology Update - Category: Psychiatry Tags: From the FDA Source Type: research